SensUs is a relatively new, international competition with an awesome goal – to find new ways to detect important molecules, including biomolecules.  For the SensUs 2017 competition, Brendan Turner in our lab has been an instrumental part.  We’d like to root him on as the team gets closer to presentation time – definitely expect updates as competition time gets closer!

The SenseNC team is a collaborative project between NC State and UNC Chapel Hill, as well as the only team in the United States to have fulfilled the requirements to compete in 2017.  If you’d like to learn more about SenseNC, either check out the international website, or get in touch with the team’s leader, Mike Wilkins (mwilkin2@ncsu.edu).

The European Patent Office has approved the patent, number EP3004136, filed by Dr. Menegatti for the purification of IgG using peptoid affinity ligands.  We think this is the beginning of an incredible journey with a new set of chemistries, one that will have many of the positive traits of our lab’s traditional expertise with peptides but the added bonuses of chemical stability.  More peptoid work from us is on the horizon as we continue to work on the cutting edge of biotechnology and bioprocessing.

Read more about the patent and the European Union patent office here.

Dr. Menegatti has been selected to speak at the Bio Manufacturing Series in 2017.   He will speak on some of our lab’s progress and innovations in the field of bioseparations and biotechnology to some of the top minds in both the industrial and academic arms of the field.

The conference was conceived to help stimulate collaboration that brings about cutting edge techniques and products.  Innovation is important within the biotechnology industry, and both this conference and our labs are dedicated to making innovation happen.

To find out more and see a list of speakers, look at the Bio Manufacturing conference’s website.